PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: STEMCELL Technologies, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2 - STEMCELL Technologies offers mTeSR™1 (defined) and TeSR™2 (animal protein-free and defined) maintenance medium for feeder-independent cultures of embryonic stem (ES) and induced pluripotent stem (iPS) cells - Stemcell.com
STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2

 

NewswireToday - /newswire/ - Vancouver, British Columbia, Canada, 2013/08/26 - STEMCELL Technologies offers mTeSR™1 (defined) and TeSR™2 (animal protein-free and defined) maintenance medium for feeder-independent cultures of embryonic stem (ES) and induced pluripotent stem (iPS) cells - Stemcell.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Some of the critical aspects of maintaining healthy ES and iPS cell cultures are outlined in the points below.

1. Appropriate matrix
Using the right matrix is critical to successful feeder-free cultures of ES and iPS cells in mTeSR™1 and TeSR™2. We recommend BD Matrigel™ hESC-qualified Matrix (BD, Catalog #354277) or Vitronectin XF™ (Catalog #07190) for mTeSR™1 cultures, and StemAdhere™ Defined Matrix for PSC (Catalog #07160) for TeSR™2 cultures. Always follow the supplier’s instructions when storing, diluting, and coating the plates with the matrices. Cells will fail to attach if plates are not coated appropriately with the right matrices. For information on how to coat plates properly with Matrigel™, please refer to our technical tip here.

2. Timing between successive passages
Using the same size and density of seeded aggregates, cells cultured in TeSR™2 grow slightly faster than those grown in mTeSR™1. Therefore mTeSR™1 cultures are usually passaged every 5-7 days, whereas TeSR™2 cultures are passaged every 4-6 days (dependent on the cell line). There is an approximate 24 hour window that is optimal for passaging cells grown in mTeSR™1 or TeSR™2. Cultures should be passaged when there are large colonies, with dense centers, and the colonies are just beginning to merge (i.e. plate is approximately 60 - 75% confluent).

3. Removing areas of differentiation
Before passaging, areas of differentiation should be selectively removed by scraping or aspirating off. If not removed, the differentiated cells will overgrow, and dominate subsequent cultures. Healthy cultures should have less than 20% differentiated areas.

4. Enzymatic or non-enzymatic passaging
For enzymatic passaging, Dispase (Catalog #07923) at 1 mg/mL is recommended to passage cells in mTeSR™1 and TeSR™2 cultures. Cells grown in TeSR™2 are slightly more sensitive to dispase than those grown in mTeSR™1, therefore the incubation period should be decreased to 3 - 4 minutes, from 5-7 min for mTeSR™1 cultures (incubation times are based on using dispase from STEMCELL Technologies; may require optimization, as there are differences in enzyme activity from different suppliers). Ensure that dispase is washed off, as residual dispase will continue to cleave the cell surface proteins that are required for the reattachment of cells to the new plates. In addition, reduce the amount of pipetting for TeSR™2 cultures, as TeSR™2 grown clumps break up easier than in mTeSR™1 and can result in undesired single cells that will die upon passage. For more information on enzymatic passaging using dispase, refer to Section 3.2.1. of the Technical Manual.

For non-enzymatic passaging, Gentle Cell Dissociation Reagent (GCDR, Catalog #07174) can be used. For more information using GCDR, refer to Section 3.2.2. of the Technical Manual.

5. Appropriate clump size for passaging
Preparation of a uniform suspension of suitable sized human ES and iPS cell clumps for passaging is critical. Clumps should be approximately 60 um 100 um in diameter (easily determined by an ocular micrometer in the microscope's eyepiece). If the clumps are too large, an increased rate of differentiation within the colonies may occur. If the clumps are too small, with many single cells present, cell survival will be compromised, decreasing the resulting number and health of colonies.

6. Plating density at time of passage
Plating density is a critical aspect of maintaining healthy human ES and iPS cells in mTeSR™1 or TeSR™2. Cultures that are either too sparsely or too densely populated can lead to differentiation. Adjust the plating density and/or split ratios to achieve a balance between having too much space between colonies and having a confluent culture. For the optimal seeding densities for different cultureware, refer to Section 5.3 of the Technical Manual.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: STEMCELL Technologies, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

STEMCELL Technologies Inc |
Publisher Contact: Press Office - Stemcell.com 
604-877-0713 marketing[.]stemcell.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STEMCELL Technologies, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From STEMCELL Technologies, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)